Stock Analysis

Assessing AdaptHealth (AHCO) Valuation After Recent Share Price Pullback and New Long-Term Contract

AdaptHealth (AHCO) has quietly slipped about 9% over the past month, even as revenue and net income keep growing. That kind of disconnect tends to catch value focused investors’ attention.

See our latest analysis for AdaptHealth.

Zooming out from the recent pullback, AdaptHealth’s 1 month share price return of minus 8.9 percent sits against a relatively modest year to date share price decline and a far more painful 3 year total shareholder return of roughly minus 57 percent. This suggests sentiment is still repairing even as fundamentals improve.

If AdaptHealth’s mix of pressure and potential has you rethinking your healthcare exposure, this could be a smart moment to scout other opportunities across healthcare stocks.

With revenue and profits rising, a moderate value score, and shares trading at a steep discount to analyst targets and estimated intrinsic value, is AdaptHealth a contrarian buy today, or is future growth already fully priced in?

Advertisement

Most Popular Narrative: 28.2% Undervalued

With AdaptHealth last closing at $9.42 against a narrative fair value a little above $13, the story leans toward meaningful upside if projections land.

The newly signed five year, $1+ billion exclusive capitated contract with a major national health system substantially increases AdaptHealth's long term base of recurring revenue. This enables predictable growth as US healthcare continues to shift toward home based delivery and value focused payer arrangements. This will drive significant topline revenue expansion beginning in 2026 and help stabilize net earnings through a higher mix of recurring/non cyclical revenue.

Read the complete narrative.

Want to see how a single contract, rising margins, and faster earnings growth combine into that upside case? The playbook and projections sit inside this narrative.

Result: Fair Value of $13.13 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, this upside depends on navigating CMS reimbursement changes and executing the capital intensive capitated contract without costly delays or margin-compressing overruns.

Find out about the key risks to this AdaptHealth narrative.

Build Your Own AdaptHealth Narrative

If you see the story differently or want to put your own assumptions to the test, you can spin up a custom view in just a few minutes: Do it your way.

A great starting point for your AdaptHealth research is our analysis highlighting 5 key rewards and 1 important warning sign that could impact your investment decision.

Looking for more investment ideas?

If you are serious about sharpening your portfolio, do not stop at AdaptHealth, use the Simply Wall Street Screener to uncover fresh, data backed opportunities today.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NasdaqCM:AHCO

AdaptHealth

Distributes home medical equipment (HME), medical supplies, and home and related services in the United States.

Very undervalued with moderate growth potential.

Advertisement

Weekly Picks

RO
RockeTeller
SCZ logo
RockeTeller on Santacruz Silver Mining ·

Crazy Undervalued 42 Baggers Silver Play (Active & Running Mine)

Fair Value:CA$8696.7% undervalued
55 users have followed this narrative
6 users have commented on this narrative
17 users have liked this narrative
RO
Robbo
FID logo
Robbo on Fiducian Group ·

Fiducian: Compliance Clouds or Value Opportunity?

Fair Value:AU$122.0% undervalued
9 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
WO
WVVI logo
woodworthfund on Willamette Valley Vineyards ·

Willamette Valley Vineyards (WVVI): Not-So-Great Value

Fair Value:US$242.5% overvalued
10 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative

Updated Narratives

DA
davidlsander
BEAM logo
davidlsander on Beam Therapeutics ·

The "Molecular Pencil": Why Beam's Technology is Built to Win

Fair Value:US$15081.9% undervalued
49 users have followed this narrative
3 users have commented on this narrative
1 users have liked this narrative
MO
mo7md
ADNOCGAS logo
mo7md on ADNOC Gas ·

ADNOC Gas future shines with a 21.4% revenue surge

Fair Value:د.إ3.728.9% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
IN
PSD logo
IncomeAssets on Pulse Seismic ·

Watch Pulse Seismic Outperform with 13.6% Revenue Growth in the Coming Years

Fair Value:CA$4.4727.3% undervalued
5 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

TH
TheWallstreetKing
MVIS logo
TheWallstreetKing on MicroVision ·

MicroVision will explode future revenue by 380.37% with a vision towards success

Fair Value:US$6098.5% undervalued
116 users have followed this narrative
11 users have commented on this narrative
22 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$250.3927.2% undervalued
957 users have followed this narrative
6 users have commented on this narrative
25 users have liked this narrative
RO
RockeTeller
SCZ logo
RockeTeller on Santacruz Silver Mining ·

Crazy Undervalued 42 Baggers Silver Play (Active & Running Mine)

Fair Value:CA$8696.7% undervalued
55 users have followed this narrative
6 users have commented on this narrative
17 users have liked this narrative